| Primary |
| Rheumatoid Arthritis |
71.5% |
| Juvenile Arthritis |
4.2% |
| Prophylaxis |
3.9% |
| Castleman's Disease |
3.3% |
| Hypertension |
2.8% |
| Product Used For Unknown Indication |
2.7% |
| Juvenile Idiopathic Arthritis |
2.5% |
| Drug Use For Unknown Indication |
1.8% |
| Osteoporosis |
1.6% |
| Pain |
1.4% |
| Diabetes Mellitus |
0.9% |
| Depression |
0.6% |
| Pancreatic Carcinoma Non-resectable |
0.4% |
| Antibiotic Prophylaxis |
0.4% |
| Constipation |
0.4% |
| Insomnia |
0.3% |
| Hyperlipidaemia |
0.3% |
| Hypothyroidism |
0.3% |
| Blood Pressure |
0.3% |
| Coronary Artery Disease |
0.3% |
|
| Pneumonia |
10.3% |
| Death |
9.2% |
| Myocardial Infarction |
7.4% |
| Rheumatoid Arthritis |
7.3% |
| Sepsis |
6.7% |
| White Blood Cell Count Decreased |
5.6% |
| Vomiting |
5.5% |
| Interstitial Lung Disease |
4.7% |
| Urinary Tract Infection |
4.7% |
| Histiocytosis Haematophagic |
4.5% |
| Skin Ulcer |
4.4% |
| Upper Respiratory Tract Inflammation |
4.4% |
| Weight Increased |
4.4% |
| Cerebrovascular Accident |
3.7% |
| Septic Shock |
3.4% |
| Pyrexia |
3.2% |
| Deep Vein Thrombosis |
2.9% |
| Cerebral Infarction |
2.7% |
| Transient Ischaemic Attack |
2.6% |
| Breast Cancer |
2.5% |
|
| Secondary |
| Rheumatoid Arthritis |
70.9% |
| Prophylaxis |
5.3% |
| Juvenile Arthritis |
5.0% |
| Juvenile Idiopathic Arthritis |
3.5% |
| Product Used For Unknown Indication |
3.4% |
| Castleman's Disease |
2.9% |
| Drug Use For Unknown Indication |
2.0% |
| Hypertension |
1.5% |
| Osteoporosis |
1.4% |
| Antibiotic Prophylaxis |
0.9% |
| Constipation |
0.5% |
| Convulsion |
0.4% |
| Diabetes Mellitus |
0.4% |
| Pain |
0.4% |
| Insomnia |
0.3% |
| Gastritis |
0.3% |
| Iron Deficiency Anaemia |
0.2% |
| Drug Eruption |
0.2% |
| Hyperlipidaemia |
0.2% |
| Thrombosis Prophylaxis |
0.2% |
|
| Upper Respiratory Tract Inflammation |
11.1% |
| Pneumonia |
10.1% |
| Interstitial Lung Disease |
7.8% |
| White Blood Cell Count Decreased |
7.7% |
| Cerebral Infarction |
6.4% |
| Sepsis |
5.0% |
| Urinary Tract Infection |
4.7% |
| Rheumatoid Arthritis |
4.5% |
| Hepatic Function Abnormal |
4.1% |
| Skin Ulcer |
4.0% |
| Renal Impairment |
3.9% |
| Weight Increased |
3.7% |
| Melaena |
3.7% |
| Tachycardia |
3.7% |
| Thrombocytopenia |
3.6% |
| Septic Shock |
3.4% |
| Thrombosis |
3.4% |
| Transient Ischaemic Attack |
3.2% |
| Hypertriglyceridaemia |
3.0% |
| Myocardial Infarction |
2.9% |
|
| Concomitant |
| Rheumatoid Arthritis |
37.7% |
| Product Used For Unknown Indication |
14.8% |
| Drug Use For Unknown Indication |
13.0% |
| Juvenile Idiopathic Arthritis |
9.0% |
| Prophylaxis |
4.7% |
| Still's Disease Adult Onset |
2.4% |
| Osteoporosis |
2.3% |
| Polyarthritis |
2.1% |
| Hypertension |
1.7% |
| Diabetes Mellitus |
1.6% |
| Folate Deficiency |
1.5% |
| Hyperlipidaemia |
1.3% |
| Musculoskeletal Pain |
1.1% |
| Myocardial Ischaemia |
1.1% |
| Nephritis |
1.1% |
| Steroid Therapy |
1.1% |
| Systemic Lupus Erythematosus |
1.1% |
| Varicella |
1.1% |
| Rheumatic Disorder |
0.8% |
| Castleman's Disease |
0.7% |
|
| Sepsis |
15.2% |
| Respiratory Failure |
10.6% |
| Interstitial Lung Disease |
7.6% |
| No Therapeutic Response |
6.1% |
| Pulmonary Fibrosis |
6.1% |
| Cytolytic Hepatitis |
4.5% |
| Intervertebral Disc Protrusion |
4.5% |
| Pain In Extremity |
4.5% |
| Pulmonary Tuberculosis |
4.5% |
| Rheumatoid Arthritis |
4.5% |
| Septic Shock |
4.5% |
| Chest Pain |
3.0% |
| Drug Ineffective |
3.0% |
| Duodenal Stenosis |
3.0% |
| Ileus |
3.0% |
| Incorrect Drug Administration Duration |
3.0% |
| Metastases To Liver |
3.0% |
| Neurodermatitis |
3.0% |
| Osteoarthritis |
3.0% |
| Palpitations |
3.0% |
|
| Interacting |
| Castleman's Disease |
52.5% |
| Prophylaxis |
14.2% |
| Rheumatoid Arthritis |
10.5% |
| Hypothyroidism |
10.2% |
| Oedema Peripheral |
8.5% |
| Product Used For Unknown Indication |
2.0% |
| Takayasu's Arteritis |
2.0% |
|
| Dizziness |
30.4% |
| Thrombosis |
21.7% |
| Dyspnoea |
17.4% |
| Urticaria |
17.4% |
| Hypercholesterolaemia |
4.3% |
| Tooth Abscess |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
|
